Decidualization of the endometrium is indispensible for pregnancy ([@B1]). The postovulatory surge in progesterone (P4) and rising cellular cAMP levels during the midluteal phase of the cycle initiate this transformational process ([@B2], [@B3]), characterized by the differentiation of stromal cells in the superficial endometrial layer into specialist decidual cells. Continuous P4 signaling is critical for maintaining and enhancing the decidual phenotype throughout pregnancy ([@B4]). In the absence of a viable pregnancy, falling P4 levels trigger proteolytic breakdown of the superficial endometrial layer, focal bleeding and menstruation or menstruation-like bleeding in the case of miscarriage ([@B5][@B6][@B8]). Aberrant decidualization has been implicated in a range of reproductive disorders including endometriosis ([@B9], [@B10]), infertility, and recurrent pregnancy loss ([@B11][@B12][@B14]).

Once the luminal endometrial epithelium is breached, migratory decidualizing stromal cells rapidly encapsulate the invading blastocyst ([@B1], [@B15], [@B16]). Emerging evidence indicates that decidual cells play a critical role in embryo biosensoring and selection ([@B17][@B18][@B19]). As pregnancy unfolds, decidual cells safeguard the conceptus against various stressors. For example, stress-induced signaling through c-Jun N-terminal kinase and p38 pathways is selectively inactivated upon decidualization of human endometrial stromal cells (HESCs) ([@B20]). Combined with the induction of various free radical scavengers, silencing of these stress-signaling pathways renders decidual cells extraordinarily resistant to oxidative cell death ([@B21][@B22][@B24]). Moreover, circadian oscillations within the endometrium are firmly disabled upon decidualization, further isolating the implanting blastocyst from the maternal environment ([@B25]).

This study investigates the role of phospholipase C (PLC)-related catalytically inactive protein 1 (PRIP-1) in decidualizing HESCs. PRIP-1, coded by *PLCL1*, is structurally homologous to members of the PLC family although it lacks catalytic activity ([@B26], [@B27]). Like PLC-enzymes, PRIP-1 contains a pleckstrin homology domain enabling binding of phosphatidylinositol 4,5-bisphosphate (PIP~2~) and other phosphoinositides. However, 2 key amino acid mutations within the catalytic domain of PRIP-1 ensure that it cannot convert PIP~2~ to inositol 1,4,5-trisphosphate (IP~3~) and diacylglycerol ([@B28]). Consequently, PRIP-1 attenuates IP~3~-dependent Ca^2+^ release from the endoplasmic reticulum (ER) ([@B29]). PRIP-1 also acts as a scaffold protein capable of binding protein phosphatase (PP)1 and PP2A as well as Protein kinase B (AKT), a serine/threonine kinase that relays growth factor signaling downstream of phosphoinositide 3-kinase (PI3K) ([@B30], [@B31]). The forkhead box protein O1 (FOXO1) is a key decidual transcription factor downstream of the PI3K/AKT pathway ([@B32][@B33][@B34]). By binding to the P4 receptor (PGR) and other decidual transcription factors, FOXO1 drives the expression of several decidual marker genes, including *PRL*, *IGFBP1*, and *WNT4* ([@B34][@B35][@B36]). However, FOXO1 is also important for cell fate decisions and up-regulates the proapototic B-cell lymphoma 2 family member BIM, coded by *BCL2L11*, upon withdrawal of P4 from decidualizing cultures, triggering cell death ([@B33]).

Gene deletions in mice highlighted the importance of both *Prip-1* and its analog *Prip-2* in reproduction. Double *Prip-1/2*-deficient mice display reduced litter sizes and exhibit prolonged intervals between litters. Furthermore, mutant female mice have smaller uteri at puberty, spend more time in estrous, and have higher gonadotrophin levels ([@B37]). *PRIP-1* has also been identified as a P4-responsive gene in the human myometrium ([@B38]). Taken together, these findings suggest that PRIP proteins are not only essential for optimal regulation of the hypothalamic-pituitary-gonadal axis but may also play a role in modulating steroid hormone responses in target tissues, such as the uterus.

Here, we report that PRIP-1 is strongly induced in decidualizing HESCs in response to P4 signaling. We show that this scaffold protein not only modulates the activity of the PI3K/AKT/FOXO1 pathway in undifferentiated HESCs but also acts as a chelator of IP~3~ signaling in decidual cells.

Materials and Methods
=====================

Patient selection and endometrial sampling
------------------------------------------

The study was approved by the National Health Service National Research Ethics-Hammersmith and Queen Charlotte\'s and Chelsea Research Ethics Committee (1997/5065). Subjects were recruited from the Implantation Clinic, a dedicated research clinic at University Hospitals Coventry and Warwickshire National Health Service Trust. Written informed consent was obtained from all participants in accordance with the guidelines in The Declaration of Helsinki 2000. Samples were obtained using a Wallach Endocell sampler (Wallach), starting from the uterine fundus and moving downward to the internal cervical ostium. A total of 43 endometrial biopsies were processed for primary cultures in this study. The average age (±SD) of the participants was 35.9 ± 4.7 years. In addition, 98 biopsies were used to measure PRIP-1 expression in vivo at mRNA and protein level. All endometrial biopsies were timed between 6 and 10 days after the preovulatory LH surge. None of the subjects were on hormonal treatments for at least 3 months before the procedure.

Primary cell culture
--------------------

HESCs were isolated from endometrial tissues as previously described ([@B4]). Purified HESCs were expanded in culture medium of DMEM/F-12 containing 10% dextran-coated charcoal-treated fetal bovine serum (DCC-FBS), L-glutamine (1%), 1% antibiotic-antimycotic solution, 2-μg/mL recombinant human insulin, and 1nM estradiol. Confluent monolayers were decidualized in DMEM/F-12 containing 2% DCC-FBS (with L-glutamine, excluding insulin and estradiol) with 0.5mM 8-bromo-cAMP (8-br-cAMP) (Sigma-Aldrich) alone or in combination with 1μM medroxyprogesterone acetate (MPA) to induce a decidual phenotype. Some cultures were also treated with dexamethasone (DEX) (0.1μM), dihydrotestosterone (DHT) (1μM), or P4 (1μM). To determine half-life time of *PRIP-1* transcripts, actinomycin D (Sigma-Aldrich) was used at a final concentration of 2μM in dimethyl sulfoxide. All experiments were carried out before the third passage.

Transient transfection
----------------------

Primary HESCs were transfected using a jetPRIME Polyplus transfection kit (VWR International). Undifferentiated HESCs were transiently transfected with 50nM PRIP-1-siGENOME SMARTpool or siGENOME nontargeting (NT) small interfering RNA (siRNA) Pool 1 (Dharmacon, GE Healthcare) for gene knockdown. Transfection studies were performed in triplicate and repeated on primary cultures from 3 or more different biopsies.

Immunohistochemistry and immunofluorescence
-------------------------------------------

Paraffin-embedded, formalin-fixed endometrial specimens were immunostained for PRIP-1 using the Novolink polymer detection system (Leica) as per manufacturer\'s instructions. Universal LSAB Plus kits (DAKO) were used as described previously ([@B39]) using primary antibodies against PRIP-1 (1:750 dilution; Sigma-Aldrich). As a negative control, the primary antibody was omitted and replaced by the corresponding IgG isotype. For confocal microscopy, primary HESCs were cultured on glass chamber slides (Thermo Scientific) and transfected with either NT or PRIP-1 siRNA. HESCs were fixed in 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton X-100 in Tris-buffered saline with 0.05% Tween (TBS-T) for 30 minutes and blocked in 1% BSA in TBS-T for 1 hour. Endogenous proteins were stained with rabbit anti-FOXO1 (2880S, 1:100; Cell Signaling Technology), followed by antirabbit fluorescein isothiocyanate (F0205, 1:500; DAKO). Cells were mounted in Vectashield with 4′,6-diamidino-2-phenylindole (Vector Labs) and visualized under a Zeiss LSM 510 META confocal microscope.

Enzyme-linked immunosorbent assay
---------------------------------

HESCs were decidualized and lysed in radioimmunoprecipitation buffer with protease inhibitors (cOmplete, Mini, EDTA-free; Roche). PRIP-1 levels in whole-cell lysates were determined using a quantitative sandwich ELISA (CusaBio) according to the manufacturer\'s protocol. The ELISA was validated by measuring PRIP-1 levels after knockdown and overexpression in cultured human myometrial cells. In spike and recovery experiments, recovered recombinant PRIP-1 within denatured samples was nonsignificant when compared with spiked concentrations ([Supplemental Figure 1](http://press.endocrine.org/doi/suppl/10.1210/en.2015-1914/suppl_file/en-15-1914.pdf)). Furthermore, inter- and intraassay data variance analysis revealed consistent coefficients of variance below 5%. Results were derived using a 4-parameter logistic regression analysis and normalized to total protein concentration as determined by Bio-Rad protein assay (Bio-Rad).

Real-time quantitative (qRT)-PCR
--------------------------------

Total RNA was extracted from HESC cultures using RNA STAT-60 (AMS Biotechnology). Equal amounts of total RNA (1 μg) were treated with deoxyribonuclease and reverse transcribed using the QuantiTect Reverse Transcription kit (QIAGEN). Resulting cDNA was used as a template in qRT-PCR analysis. Detection of gene expression was performed with Power SYBR Green Master Mix (Life Technologies) using the 7500 Real Time PCR System (Applied Biosystems). The expression levels of the samples were calculated using the ΔΔC~T~ method, incorporating the efficiencies of each primer pair. Reaction specificity was confirmed by dissociation curve analysis. *L19* was used as a reference gene for normalization. All measurements were performed in triplicate. Primer sequences used were as follows: *IGFBP1* forward, 5′-cga agg ctc tcc atg tca cca-3′ and *IGFBP1* reverse, 5′-tgt ctc ctg cct tgg cta aac-3′; *L19* forward, 5′-gcg gaa ggg tac agc caa-3′ and *L19* reverse, 5′-gca gcc ggg cgc aaa-3′; *PRIP-1* forward, 5′-gca gca gca tca tca agg-3′ and *PRIP-1* reverse, 5′-gct gct gaa aga cac ggt tt-3′; *PRL* forward, 5′-aag ctg tag aga ttg agg agc aaa c-3′ and *PRL* reverse, 5′-tca gga tga acc tgg ctg act a-3′; and *WNT4* forward, 5′- gca gag ccc tca tga acc t-3′ and *WNT4* reverse, 5′-cac cgc atg tgt gtc ag-3′.

Western blot analysis and proteome array
----------------------------------------

Whole-cell protein extracts were prepared by lysing cells in radioimmunoprecipitation buffer containing protease inhibitors (cOmplete, Mini, EDTA-free; Roche). For nuclear and cytoplasmic protein fractionation, cells were lysed in Buffer A (10mM HEPES, 10mM KCl, and 0.1mM EDTA), centrifuged at 100*g*, and the supernatant containing the cytoplasmic fraction collected. The remaining pellet was then lysed on ice in high salt buffer (5mM HEPES, 1.5mM MgCl~2~, 0.2mM EDTA, and 300mM NaCl) for 10 minutes, centrifuged, and the supernatant, containing the nuclear fraction, retained. Protein yield was measured using the Bradford assay. Equal amounts of protein were separated by SDS-PAGE and wet transfer onto polyvinylidene difluoride (PVDF) membrane (GE Healthcare UK). Nonspecific binding sites were blocked by incubation with 5% nonfat dry milk in TBS-T (130 mmol/L NaCl, 20 mmol Tris \[pH 7.6\], and 0.05% Tween). The primary antibodies used are tabulated in [Table 1](#T1){ref-type="table"}. Protein complexes were visualized with ECL Plus chemiluminescence (GE Healthcare). Relative phosphorylation of 26 phospho-kinases was determined by Proteome Profiler Human Phospho-MAPK array kit (R&D Systems). The array was performed according to manufacturer\'s specifications using 250-μg total protein lysates. Blots were visualized after exposure to chemiluminescent reagents and densitometry performed with individual phospho-proteins expressed as a percentage of reference dots.

###### 

Antibody Table

  Protein Target   Manufacturer                              Dilution
  ---------------- ----------------------------------------- -------------------------------------
  PRIP-1           Sigma-Aldrich (HPA031849)                 WB 1:500 immunohistochemistry 1:750
  AKT              Cell Signaling Technology (4691)          WB 1:1000
  p-AKT (Ser473)   Cell Signaling Technology (4060)          WB 1:1000
  FOXO1A           Cell Signaling Technology (2880)          WB 1:1000
  BIM              Cell Signaling Technology (2933)          WB 1:1000
  VINCULIN         Abcam (ab18058)                           WB 1:1000
  LAMIN A/C        Santa Cruz Biotechnology, Inc (sc-7292)   WB 1:500
  β-ACTIN          Abcam (ab8226)                            WB 1:10 000

Confocal imaging of intracellular Ca^2+^ (\[Ca^2+^\]~i~) oscillations
---------------------------------------------------------------------

Decidualizing HESCs were washed in modified Krebs\'-Henseleit buffer (133 mmol/L NaCl, 4.7 mmol/L KCl, 11.1 mmol/L glucose, 1.2 mmol/L MgSO~4~, 1.2 mmol/L KH~2~PO~4~, 2.5 mmol/L CaCl, and 10 mmol/L TES; pH 7.4 at 37°C) and loaded with 5μM Fluo-4-AM for 1 hour at room temperature. Cells were washed and incubated in 2-mL Krebs\'-Henseleit buffer. The glass-bottomed Petri dish containing Fluo-4-loaded cells was secured in a spring-loaded holder in a temperature-controlled environmental chamber on the stage of an inverted microscope (Axiovert 200M) equipped with an LSM 510 META confocal scanner (Carl Zeiss). Cells were excited with a krypton/argon laser at 488 nm and emitted light collected above 510 nm through a ×40 oil immersion objective lens. Decidualizing cells transfected with PRIP-1 or NT siRNA were challenged with 5μM *m*-3M3FBS or vehicle by direct addition into the cell-containing Petri dish. Image sequences of Fluo-4 fluorescence were recorded for 10 minutes at a rate of approximately one frame per second and used as an indication of changes in \[Ca^2+^\]~i~. Videos were analyzed using LSM image analysis software. Averaged fluorescence intensity was measured in regions of interest placed over individual cells and expressed as a fold increase from time 0 (F/F~0~). Data traces were plotted and peak response, integral (area under the curve; baseline y = 1) and oscillatory frequency (Hz) were measured.

Viability and proliferation assays
----------------------------------

The number of viable cells was assessed by trypan blue exclusion. Cells were counted on the Luna cell counter (Logosbio), and percentage viability calculated. Apoptosis was assessed by measurement of the activities of caspase 3/7 using Apo-One Homogenous kit (Promega) according to manufacturer\'s guidelines. Cleavage of a nonfluorescent substrate by caspase 3/7 resulted in fluorescence, measured at 530-nm emission and 490-nm excitation on the PHERAStar FS microplate reader (BMG Labtect). Real-time adherent cell proliferation was determined by the label-free xCELLigence Real-Time Cell Analyzer (RTCA) DP instrument (Roche Diagnostics GmbH). HESCs were seeded into 16-well plates (E-plate-16; Roche Diagnostics GmbH) at a density of 10 000 cells per well and cultured in 10% DCC-FBS until reaching approximately 80% confluency. The RTCA DP instrument was placed at 37°C in a humidified environment with 95% air and 5% CO~2~. Individual wells within the E-plate-16 were referenced immediately and measured first every 15 minutes for 3 hours and then hourly for 100 hours. Changes in cell index were analyzed using RTCA Software v1.2.

Statistical analysis
--------------------

Data were analyzed with the statistical package GraphPad Prism v6 (GraphPad Software, Inc). Unpaired Student\'s *t* test, Mann-Whitney *U* test and Pearson\'s correlation were used when appropriate. Statistical significance was assumed at *P* \< .05. In the actinomycin D experiments, *PRIP-1* mRNA half-life was calculated using t~1/2~ = 0.693/k, where k is the slope derived from a linear equation lnC = *ln*C~0~ − kt, and where C is the relative level of *PRIP-1* mRNA in HESCs ([@B40]).

Results
=======

Induction of PRIP-1 in response to P4 signaling
-----------------------------------------------

*PRIP-1* mRNA and protein levels were measured in undifferentiated HESCs and cells decidualized for 2, 4, or 8 days ([Figure 1](#F1){ref-type="fig"}A). Decidualization was associated with marked up-regulation of *PRIP-1* transcripts with levels rising more than 30-fold within 48 hours of differentiation. The induction of *PRIP-1* mRNA was then maintained over the 8-day time course. By contrast, induction of PRIP-1 protein was more gradual and expression peaked on day 8 of decidualization ([Figure 1](#F1){ref-type="fig"}A, lower panel). To define the signaling pathway that drives *PRIP-1* in differentiating HESCs, 3 independent primary cultures were treated with either 8-br-cAMP, MPA, or a combination ([Figure 1](#F1){ref-type="fig"}B). Although 8-br-cAMP up-regulated *PRIP-1* mRNA levels modestly (∼3-fold) after 4 days of treatment, MPA triggered a robust induction (∼25-fold). Combined treatment did not yield an additive effect ([Figure 1](#F1){ref-type="fig"}B, upper panel), indicating that induction of *PRIP-1* is primarily dependent on P4 signaling. Regulation at protein level was somewhat divergent as 8-br-cAMP augmented the induction of PRIP-1 in response to MPA treatment ([Figure 1](#F1){ref-type="fig"}B, lower panel). We speculated that the rise in *PRIP-1* transcripts in decidualizing cells could, at least partly, reflect increased RNA stability. To test this hypothesis, undifferentiated and decidualized HESCs were treated with actinomycin D, a potent transcription inhibitor, for 0.5, 1, 2, 4, or 8 hours. The half-life of *PRIP-1* mRNA in decidualizing cells was nonsignificantly higher when compared with undifferentiated cells (4.9 vs 3.6 h, respectively; *P* \> .05), indicating that the rise in *PRIP-1* is primarily accounted for by P4-dependent transcription. MPA is not only a potent activator of the PGR but also exhibits glucocorticoid- and androgen-like activities in HESCs ([@B41]). To determine whether *PRIP-1* is indeed a P4-responsive gene, primary HESC cultures were treated either with DEX, DHT, P4, or MPA. As show in [Figure 1](#F1){ref-type="fig"}D, the induction of *PRIP-1* transcripts in cultures treated with P4 was comparable with the response with MPA. Notably, DHT but not DEX triggered a small but significant increase in *PRIP-1* expression (*P* \< .05).

![P4 regulates *PRIP-1* expression in HESCs.\
A, PRIP-1 transcript and protein levels were measured in undifferentiated HESCs and cells decidualized with 8-br-cAMP and MPA for 2, 4, or 8 days. The upper panel shows fold induction of *PRIP-1* mRNA (mean ± SEM) in 3 independent primary cultures relative to expression in undifferentiated cells. Total protein lysates from parallel cultures were subjected to Western blotting (lower panel). β-Actin served as a loading control. B, Primary HESC cultures were treated with either 8-br-cAMP, MPA, or a combination for 96 hours. The upper panel shows the relative increase in *PRIP-1* mRNA levels (mean ± SEM) compared with vehicle-treated undifferentiated HESC cultures established from 3 biopsies. The lower panel shows the corresponding protein levels, determined by Western blotting. β-Actin served as a loading control. C, Primary cultures (n = 3) remained undifferentiated or were decidualized for 96 hours before treatment with 2μM actinomycin D. RNA was extracted at the indicated time points and subjected to qRT-PCR analysis. D, Primary HESCs isolated from 3 different biopsies were treated with DEX, DHT, P4, MPA, or vehicle (control). Total RNA was harvested 96 hours later and subjected to qRT-PCR analysis. The data show induction of *PRIP-1* transcripts (mean ± SEM) relative to control cells. E, *PRIP-1* transcripts were measured after withdrawal of MPA for the indicated time points in 3 separate cultures first decidualized with 8-br-cAMP and MPA for 96 hours. *PRIP-1* mRNA levels were normalized to the level of expression in undifferentiated cells (dotted line). F, Total protein lysates were harvested from parallel cultures PRIP-1 protein levels determined by ELISA; \*, *P* \< .05; \*\*, *P* \< .01.](zee0061685150001){#F1}

Finally, we investigated the expression of PRIP-1 in decidualizing cells upon withdrawal of deciduogenic signals. Parallel cultures were differentiated with 8-br-cAMP and MPA for 4 days. The decidualization stimulus was then withdrawn for 12, 24, 48, or 72 hours and cultures harvested for mRNA and protein analyses. Interestingly, PRIP-1 transcript levels fell by 50% within 24 hours after withdrawal of 8-br-CAMP and MPA but then remained stable over the remainder of the time course ([Figure 1](#F1){ref-type="fig"}E). By contrast, PRIP-1 protein levels, measured by ELISA, declined only modestly (20%) 72 hours after withdrawal of 8-br-cAMP and MPA ([Figure 1](#F1){ref-type="fig"}F). Taken together, the data reveal a significant lag period between the rapid induction of *PRIP-1* transcript levels in response to progestin signaling and the gradual rise in protein levels. Once induced, PRIP-1 expression is stable and relatively resistant to P4 withdrawal.

PRIP-1 expression in luteal phase endometrium
---------------------------------------------

Immunohistochemical analysis of midluteal endometrial biopsies revealed that PRIP-1 is widely expressed in both the epithelial and stromal compartments ([Figure 2](#F2){ref-type="fig"}A). PRIP-1 immunoreactivity, however, was heterogeneous, especially in the stromal compartment with some cells staining intensely, whereas others showed little expression ([Figure 2](#F2){ref-type="fig"}A). Mining of the GEO database (GDS2052) revealed that endometrial *PRIP-1* mRNA levels increase markedly during the early-luteal phase, presumably in response to the rapid rise in postovulatory P4 levels. Transcript levels then decline and by the late luteal phase are comparable with proliferative phase endometrium ([Figure 2](#F2){ref-type="fig"}B). Detailed analysis of timed endometrial biopsies (LH+6 to LH+10) indicated that PRIP-1 expression is relatively stable over the periimplantation window. Notably, although transcript levels appeared to decline as the cycle progresses to the late luteal phase (Spearman\'s ρ = −0.1753, *P* = .0812) ([Figure 2](#F2){ref-type="fig"}C), PRIP-1 protein levels, measured by ELISA, remained stable (Spearman\'s ρ = 0.2421, *P* = .2437) ([Figure 2](#F2){ref-type="fig"}D).

![PRIP-1 expression in midluteal endometrium.\
A, Immunohistochemistry of midluteal endometrial biopsies demonstrates heterogeneous expression of PRIP-1 in both stromal and epithelial cells. B, Comparison of endometrial *PRIP-1* transcripts, expressed in arbitrary units (A.U.), in proliferative, early-, mid-, and late-secretory endometrium. The data were derived from in silico analysis of publicly available microarray data (GEO Profiles; ID, GDS2052); \*, *P* \< .05. C, *PRIP-1* transcript levels were measured by qRT-PCR in 73 endometrial biopsies obtained between 6 and 10 days after the LH surge (LH+). D, PRIP-1 protein levels were measured, in triplicate, in 25 whole endometrial samples by ELISA. Dotted lines represent 95% confidence intervals.](zee0061685150002){#F2}

Survival function of PRIP-1 in undifferentiated HESCs
-----------------------------------------------------

siRNA-mediated knockdown experiments were performed to examine the function of PRIP-1 in HESCs. Knockdown of this scaffold protein was highly effective; it not only abolished the induction of PRIP-1 in cells decidualized for 4 days but also lowered basal expression in undifferentiated HESCs ([Figure 3](#F3){ref-type="fig"}A). A trypan blue exclusion assay revealed a 28% reduction in numbers of live cells in undifferentiated HESCs transfected with PRIP-1 siRNA ([Figure 3](#F3){ref-type="fig"}B). In parallel, caspase-3 and caspase-7 activities increased by more than 3-fold ([Figure 3](#F3){ref-type="fig"}C). Notably, loss of PRIP-1 did not compromise the viability of differentiating cells treated with MPA and 8-br-cAMP ([Figure 3](#F3){ref-type="fig"}, B and C). Real-time monitoring of cell proliferation over 100 hours using microelectronic sensor technology (xCELLigence) confirmed that PRIP-1 knockdown completely abolished expansion of undifferentiated HESCs in culture ([Figure 3](#F3){ref-type="fig"}D). To determine how PRIP-1 exerts its survival function, total protein lysates from HESCs first transfected with NT or PRIP-1 siRNA were hybridized to a proteome array. Analysis of the relative phosphorylation levels of 26 kinases revealed that PRIP-1 knockdown selectively inhibits AKT activation ([Figure 3](#F3){ref-type="fig"}E). Phosphorylation levels of AKT1 (S473), AKT2 (S474), AKT3 (S472), and pan-AKT (S473, S474, and S472) were reduced by 69%, 59%, 46%, and 58%, respectively. We speculated that loss of AKT activity upon PRIP-1 knockdown would attenuate FOXO1 turnover by promoting nuclear translocation of this transcription factor ([@B42]). Western blot analysis of total protein lysates provided support for this conjecture and further revealed that the increase in FOXO1 levels in undifferentiated HESCs transfected with PRIP-1 coincided with induction of BIM, a well-characterized proapoptotic FOXO1 target ([Figure 3](#F3){ref-type="fig"}F) ([@B43]). Analysis of fractionated cytoplasmic and nuclear proteins confirmed that PRIP-1 knockdown increases nuclear FOXO1 levels ([Figure 3](#F3){ref-type="fig"}G). However, confocal analysis revealed cellular heterogeneity in this response with some stromal cells displaying intense nuclear FOXO1 staining, whereas other cells did not ([Figure 3](#F3){ref-type="fig"}H).

![PRIP-1 is a survival factor in undifferentiated HESCs.\
A, Three independent primary cultures were transfected with either NT or PRIP-1 siRNA. After 48 hours, some cultures were decidualized for 96 hours, whereas others remained untreated. PRIP-1 mRNA and protein levels were measured in parallel cultures by qRT-PCR (upper panel) and Western blotting (lower panel), respectively. Transcript levels were normalized to expression in undifferentiated cells transfected with NT siRNA; \*\*\*, *P* \< .001. B, Cell viability as measured by trypan blue exclusion assay in 3 independent primary cultures first transfected with either NT or PRIP-1 siRNA. After transfection, the cultures remained either untreated or were decidualized for 96 hours. Data normalized to untransfected control (dotted line); \*\*, *P* \< .01. C, In parallel experiments, caspase 3/7 activity was measured and expressed in fluorescent intensity units (F.I.U.). The data represent mean (±SEM) activity in 3 independent cultures; \*\*, *P* \< .01 and \*\*\*, *P* \< .001. D, Real-time monitoring of the growth of undifferentiated HESCs over 100 hours after transfection with NT or PRIP-1 siRNA. E, Protein lysates from undifferentiated HESC transfected with either NT or PRIP-1 siRNA were subjected to proteome profiler MAPK array membranes and analyzed by densitometry; \*, *P* \< .05 and \*\*\*, *P* \< .01. F, Western blot analysis of total protein lysates from undifferentiated HESCs 48 hours after transfection with either NT or PRIP-1 siRNA. G, Nuclear accumulation of FOXO1 was confirmed by Western blot analysis of cytoplasmic and nuclear cell fractions. VINCULIN and LAMIN A/C confirmed enrichment of the cytoplasmic and nuclear proteins, respectively. H, Confocal microscopy showing FOXO1 immunoreactivity in primary HESCs transfected with either NT or PRIP-1 siRNA. Arrowheads indicate cells characterized by marked nuclear FOXO1 accumulation.](zee0061685150003){#F3}

Expression of decidual markers in response to PRIP-1 knockdown
--------------------------------------------------------------

We next examined whether PRIP-1 is important for the expression of decidual marker genes. When compared with cell transfected NT siRNA, knockdown of PRIP-1 before decidualization reduced the overall levels of *PRL*, *IGFBP1*, and *WNT4* transcripts after 4 days of treatment with 8-br-cAMP and MPA. However, only the reduction in WNT4 mRNA was statistically significant (*P* \< .05). Furthermore, basal expression of these 3 genes in undifferentiated cells was significantly lower ([Figure 4](#F4){ref-type="fig"}A). Consequently, the overall responsiveness to deciduogenic signals, determined by fold induction, was unaffected upon PRIP-1 knockdown; and in case of *PRL* even significantly enhanced ([Figure 4](#F4){ref-type="fig"}B).

![PRIP-1 blunts the overall expression of differentiation markers in decidualizing HESCs.\
A, Three independent primary HESCs were first transfected with NT or PRIP-1 siRNA. The cultures then remained untreated or were decidualized with 8-br-cAMP and MPA. The data shows relative expression (mean ± SEM) of decidual marker genes. B, The same data expressed as fold induction in transcript level relative to the basal levels in undifferentiated cells transfected with NT or PRIP-1 siRNA; \*, *P* \< .05 and \*\*\*, *P* \< .01.](zee0061685150004){#F4}

PRIP-1 inhibits PLC-dependent Ca^2+^ signaling
----------------------------------------------

We hypothesized that induction of PRIP-1 in decidualizing cells could serve to silence PLC-dependent Ca^2+^ signaling through PIP~2~/IP~3~ chelation. To test this conjecture, primary HESCs were transfected with either NT or PRIP-1 siRNA before decidualization for 4 days. The cultures were then loaded with the fluorescent Ca^2+^ indicator Fluo-4 and challenged with the PLC activator *m*-3M3FBS or vehicle (dimethyl sulfoxide). Decidualizing cultures transfected with NT siRNA displayed minimal \[Ca^2+^\]~i~ oscillations in response to PLC activation. By contrast, cells transfected with PRIP-1 siRNA exhibited robust and sustained \[Ca^2+^\]~i~ fluxes over the entire recording ([Figure 5](#F5){ref-type="fig"}A). Analysis of 4 independent cultures revealed PRIP-1 knockdown resulted in 2-fold increase in oscillation frequency, 2-fold increase in peak fluorescence, and 3-fold increase in the area under the curve ([Figure 5](#F5){ref-type="fig"}B) in response to PLC activation. These results support the conjecture that the sustained induction of PRIP-1 in decidualizing HESCs acts to sequester phosphoinositides and to limit \[Ca^2+^\]~i~ release.

![PRIP-1 blocks PLC-dependent Ca^2+^ signaling in decidual cells.\
A, HESCs cultured in glass bottomed Petri dishes were transfected with NT (left panel) or PRIP-1 (right panel) siRNA and decidualized for 4 days. Cells were then loaded with 5μM Fluo-4-AM and challenged with 5μM *m*-3M3FBS or vehicle (data not shown) at the indicated time point. Cytosolic fluorescence recorded by confocal microscopy over 10 minutes was used as an index of \[Ca^2+^\]~i~. Traces showing fluorescence within individual cells, transfected either with NT (left panel) or PRIP-1 siRNA (right panel) are expressed as a fold increase over fluorescence at time 0 (F/F~0~). Data were obtained from 4 independent cultures. B, Traces were analyzed to assess the peak changes in fluorescence, the integral, and oscillation frequency (Hz). Data show mean ± SEM; \*\*\*\*, *P* \< .0001.](zee0061685150005){#F5}

Discussion
==========

By activating its cognate nuclear receptor, P4 controls the expression of numerous genes that encode membrane-bound receptors and intermediates in various signal transduction pathways in differentiating HESCs ([@B1], [@B44]). Consequently, P4 transforms the processing of cellular signals and environmental cues upon decidualization. For example, knockdown of PGR is sufficient to inhibit activation of the WNT/β-catenin, TGFβ/SMAD, and signal transducer and activator of transcription pathways in decidualizing cells ([@B44]). P4 also induces MAPK phosphatase 1 (DUSP1) ([@B45]), which in turn disables c-Jun N-terminal kinase and p38 stress-responsive pathways in decidualizing HESCs ([@B46]). We now report that P4 strongly up-regulates PRIP-1 expression in HESCs. Once induced, this scaffold protein accumulates in decidualizing HESCs, and levels remain relatively stable even upon withdrawal of progestins.

Unexpectedly, knockdown experiments demonstrated that basal PRIP-1 levels are critical for survival of undifferentiated HESCs. This antiapoptotic function of PRIP-1 is predicated on its ability to regulate the activity of AKT, either by facilitating interaction with upstream kinases or, conversely, by sequestering AKT phosphatases such as PP2A ([@B31]). AKT-dependent phosphorylation of FOXO1 leads to its nuclear export, ubiquitination mediated by E3 ligases such as S-phase kinase-associated protein 2 and mouse double minute 2 homolog, and proteasomal degradation ([@B47], [@B48]). PRIP-1 deficiency in HESCs selectively reduced AKT activity by more than 50%, which was sufficient to increase nuclear FOXO1 levels and activate the proapoptotic machinery. Notably, loss of cell viability upon PRIP-1 knockdown was only partial. It is increasingly appreciated that primary HESC cultures consist of distinct communities of cells, including clonogenic mesemchymal, mature progeny, perivascular SUSD2-positive cells, and senescent fibroblasts ([@B11], [@B51]). Hence, it is not inconceivable that some but not all subpopulations of HESCs are dependent on PRIP-1 for survival, although this conjecture requires further testing.

PRIP-1 knockdown did not interfere with the responsiveness of the HESCs to deciduogenic cues. This is not surprising as FOXO1 accumulates in the nuclei of differentiating HESCs where it binds other decidual transcription factors, including PGR, homeobox A11, and CCAAT/Enhancer binding protein beta resulting in formation of transcriptional complexes that activate differentiation genes, including *WNT4*, *PRL*, and *IGFBP1* ([@B32], [@B34], [@B35], [@B52]). Unexpectedly, basal expression levels of *WNT4*, *PRL*, and *IGFBP1* were markedly lower in undifferentiated HESCs transfected with PRIP-1 siRNA. A parsimonious explanation for this intriguing observation is that loss of PRIP-1 triggers apoptosis in a subpopulation of HESCs, characterized by relatively high basal expression of decidual markers. Notably, knockdown of FOXO1 in decidualizing HESC cultures completely eliminates apoptosis upon progestin withdrawal ([@B33], [@B42]), indicating that the ability of FOXO1 to switch between apoptosis and differentiation targets is dependent on P4 signaling.

Up-regulation of PRIP-1 in decidual cells may primarily serve to silence PLC signaling downstream of G~q~ protein-coupled receptors. Upon implantation, decidual cells form a nutritive matrix for trophoblast invasion that is relatively autonomous and resistant to potentially harmful maternal inputs. Various mechanisms underpinning decidual resistance have been described, including silencing of circadian oscillations ([@B25]), massive increase in cellular ROS-scavenging potential ([@B21], [@B23]), global cellular hypo-SUMOylation ([@B3], [@B22]), and the aforementioned inhibition of stress-responsive pathways ([@B20], [@B22]). These adaptations ensure unimpeded P4 signaling even under conditions of intense tissue remodeling and changing oxygen tension at the feto-maternal interface ([@B22]). The trophic function of decidual cells depends on acquisition of a secretory phenotype, which in turn requires rapid expansion of the ER in differentiating HESCs. Ergo, differentiating HESCs mount a physiological unfolded protein response characterized by up-regulation of various molecular chaperones, including protein disulfide isomerase, binding immunoglobulin protein, endoplasmic oxidoreductin-1α, and calnexin ([@B17]). We now show that, by chelating IP~3~, PRIP-1 limits Ca^2+^ release from the expanding ER, which arguably safeguards decidual cells against excessive Ca^2+^ accumulation in the mitochondrial matrix, permeabilization of the mitochondrial outer membrane and subsequent apoptosis ([@B53]). Interestingly, PRIP-1 also inhibits autophagosome formation by binding to microtubule-associated protein 1 light chain 3, a key initiator of the autophagy pathway ([@B54]). The importance of these pathways in the endometrium is underscored by recent observations demonstrating that ER stress and autophagy in decidual cells mediate recognition and rejection of developmentally compromised human embryos ([@B17]). Arguably, silencing PLC signaling downstream of G~q~ protein-coupled receptors may also enhance the biosensoring function of decidual cells by restricting signaling to discrete embryonic cues.

In conclusion, PRIP-1 is a versatile P4-inducible scaffold protein in the endometrium. Our data suggest that the function of PRIP-1 switches from amplifying AKT activity in proliferating HESCs to inhibiting PLC signaling downstream of G~q~ protein-coupled receptors in decidual cells. The role of PRIP-1 in regulating the responses of decidual cells to embryonic and trophoblast signals warrants further investigation.
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